PUBLISHER: Value Market Research | PRODUCT CODE: 1342786
PUBLISHER: Value Market Research | PRODUCT CODE: 1342786
Global Beta Thalassemia Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
The global demand for Beta Thalassemia Testing Market is presumed to reach the market size of nearly USD 1214.63 BN by 2030 from USD 501.83 BN in 2022 with a CAGR of 9.2% under the study period 2023 - 2030.
Beta thalassemia is a type of blood disorder. This is a genetic disease in which the body produces less haemoglobin than usual. Haemoglobin is a protein containing iron and is present in red blood cells; the major function of haemoglobin is to carry oxygen to the body cells throughout the body. Beta thalassemia causes a huge number of blood cells to be destroyed. The condition is characterized by anemia, shortness of breath, fatigue, fast heartbeat, irritability, jaundice, and slow growth. Beta thalassemia testing consists of blood transfusions and iron chelation therapy.
MARKET DYNAMICS:
The increase in the prevalence of thalassemia may be a major contributor to market growth. Another significant factor influencing the beta thalassemia market growth rate is the rising healthcare expenditure. Also, the rise in the adoption rate of early genetic testing and counselling will boost market growth. Moreover, government measures to raise awareness of thalassemia may propel market growth. Furthermore, increased R&D activities and the launch of effective treatments offer lucrative market opportunities. However, the high cost associated with the treatment may limit the market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of beta thalassemia testing. The growth and trends of beta thalassemia testing industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the beta thalassemia testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- Kits
- Consumables
By Technology
- Prenatal Diagnosis
- Complete Blood Count
- Dna Testing
- Others
By Type
- Thalassemia Major
- Thalassemia Intermedia
By End-User
- Hospitals & Specialty Clinics
- Diagnostics Centers
- Others
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the Beta Thalassemia Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the beta thalassemia testing market include MedGenome, 3B BlackBio Biotech India Limited, Bio-Rad Laboratories Inc., ViennaLab Diagnostics, Thermo Fisher Scientific Inc., PerkinElmer Inc., BioMedomics Inc., Asper Biogene, Tosoh Bioscience Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . BETA THALASSEMIA TESTING - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Type
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY PRODUCT
- 6.1 Overview by Product
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Product
- 6.4 Kits Historic and Forecast Sales by Regions
- 6.5 Consumables Historic and Forecast Sales by Regions
7 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY TECHNOLOGY
- 7.1 Overview by Technology
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Technology
- 7.4 Prenatal Diagnosis Historic and Forecast Sales by Regions
- 7.5 Complete Blood Count Historic and Forecast Sales by Regions
- 7.6 DNA Testing Historic and Forecast Sales by Regions
- 7.7 Others Historic and Forecast Sales by Regions
8 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY TYPE
- 8.1 Overview by Type
- 8.2 Historical and Forecast Data
- 8.3 Analysis by Type
- 8.4 Thalassemia Major Historic and Forecast Sales by Regions
- 8.5 Thalassemia Intermedia Historic and Forecast Sales by Regions
9 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY END-USER
- 9.1 Overview by End-user
- 9.2 Historical and Forecast Data
- 9.3 Analysis by End-user
- 9.4 Hospitals & Specialty Clinics Historic and Forecast Sales by Regions
- 9.5 Diagnostics Centers Historic and Forecast Sales by Regions
- 9.6 Others Historic and Forecast Sales by Regions
10 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY GEOGRAPHY
- 10.1. Regional Outlook
- 10.2. Introduction
- 10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
- 10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
- 10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
- 10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
- 10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis
11 . COMPETITIVE LANDSCAPE OF THE BETA THALASSEMIA TESTING COMPANIES
- 11.1. Beta Thalassemia Testing Market Competition
- 11.2. Partnership/Collaboration/Agreement
- 11.3. Merger And Acquisitions
- 11.4. New Product Launch
- 11.5. Other Developments
12 . COMPANY PROFILES OF BETA THALASSEMIA TESTING INDUSTRY
- 12.1. Top Company Share Analysis
- 12.2. Market Concentration Rate
- 12.3. MedGenome
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
- 12.4. 3B BlackBio Biotech India Limited
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
- 12.5. Bio-Rad Laboratories Inc.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
- 12.6. ViennaLab Diagnostics
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
- 12.7. Thermo Fisher Scientific Inc.
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
- 12.8. PerkinElmer Inc.
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
- 12.9. BioMedomics Inc.
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
- 12.10. Asper Biogene
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
- 12.11. Tosoh Bioscience Inc.
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Analysis by Product (USD MN)
- Kits Market Sales by Geography (USD MN)
- Consumables Market Sales by Geography (USD MN)
- Analysis Market by Technology (USD MN)
- Prenatal Diagnosis Market Sales by Geography (USD MN)
- Complete Blood Count Market Sales by Geography (USD MN)
- DNA Testing Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis by Type (USD MN)
- Thalassemia Major Market Sales by Geography (USD MN)
- Thalassemia Intermedia Market Sales by Geography (USD MN)
- Analysis by End-user (USD MN)
- Hospitals & Specialty Clinics Market Sales by Geography (USD MN)
- Diagnostics Centers Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Beta Thalassemia Testing Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Beta Thalassemia Testing Report
- Market Research Process
- Market Research Methodology
- Global Beta Thalassemia Testing Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Product
- Market Attractiveness Analysis by Technology
- Market Attractiveness Analysis by Type
- Market Attractiveness Analysis by End-user
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Product (USD MN)
- Kits Market Sales by Geography (USD MN)
- Consumables Market Sales by Geography (USD MN)
- Global Market Analysis by Technology (USD MN)
- Prenatal Diagnosis Market Sales by Geography (USD MN)
- Complete Blood Count Market Sales by Geography (USD MN)
- DNA Testing Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by Type (USD MN)
- Thalassemia Major Market Sales by Geography (USD MN)
- Thalassemia Intermedia Market Sales by Geography (USD MN)
- Global Market Analysis by End-user (USD MN)
- Hospitals & Specialty Clinics Market Sales by Geography (USD MN)
- Diagnostics Centers Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Company Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
